April 25-27, 2017 – San Francisco, USA

The 5^th annual RNA-Seq meeting  will  provide a vital forum for scientists, bioinformaticians and pharmaceutical business leaders to come up to speed with the latest advances in RNA-Seq technologies and analytical tools, and address key challenges surrounding their practical application to drug development and the clinic.

What’s new to RNA-Seq 2017?

• Discover new cases studies giving you unprecedented access to both the data and results of how RNA-Seq is being applied successfully from bench to bedside

• Gain new insights into RNA-Seq for the study of toxicity, IO, host-viral interactions and more from companies such as BMS, Janssen, Pfizer, Merck, UCSC and Stanford

• Explore new solutions to:
  • Roadblocks in applying single cell and other emerging RNA sequencing technologies in the clinic
  • Accurately interpreting the vast amounts of data in unpicking the complexity of the transcriptome
  • Integrating and mining of RNA-Seq data for drug discovery research
  • Novel and innovative RNA-Seq methods to understand the impact of tissue composition and cellular  interactions

Download the agenda for the complete agenda and speaker faculty.

For more information or to secure your place today, visit www.rna-seqsummit.com or email me if you have any questions.